Analyst Brandon Henry works at RBC and is focused on the Healthcare sector with 231 price targets and ratings documented since 2009 spanning on 9 stocks. Analyst's average stock valuation to be materialised ratio is 96.33% with an average time for price targets to be met of 406.89 days.
Most recent stock forecast was given on EW, Edwards Lifesciences Corporation at 28-Nov-2022.
Brandon Henry best performing recommendations are on NUVA (NUVASIVE, INC).
The best stock recommendation documented was for NUVA (NUVASIVE, INC) at 5/5/2011. The price target of $32 was fulfilled within 1 day with a profit of $1.34 (4.37%) receiving and performance score of 43.71.
Average potential price target upside